This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003 Dec;144(12):5145-8.

doi: 10.1210/en.2003-1147.

Glucagon-like peptide-1 and the islet beta-cell: augmentation of cell proliferation and inhibition of apoptosis

Daniel J Drucker¹

Affiliations

Affiliation

¹ Department of Medicine, Banting and Best Diabetes Centre, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada M5G 2C4. d.drucker@utoronto.ca.

PMID: 14645210
DOI: 10.1210/en.2003-1147

Review

Glucagon-like peptide-1 and the islet beta-cell: augmentation of cell proliferation and inhibition of apoptosis

Daniel J Drucker. Endocrinology. 2003 Dec.

. 2003 Dec;144(12):5145-8.

doi: 10.1210/en.2003-1147.

Author

Daniel J Drucker¹

Affiliation

¹ Department of Medicine, Banting and Best Diabetes Centre, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada M5G 2C4. d.drucker@utoronto.ca.

PMID: 14645210
DOI: 10.1210/en.2003-1147

No abstract available

PubMed Disclaimer

Comment on

Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.
Farilla L, Bulotta A, Hirshberg B, Li Calzi S, Khoury N, Noushmehr H, Bertolotto C, Di Mario U, Harlan DM, Perfetti R. Farilla L, et al. Endocrinology. 2003 Dec;144(12):5149-58. doi: 10.1210/en.2003-0323. Epub 2003 Aug 28. Endocrinology. 2003. PMID: 12960095

Similar articles

Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.
Drucker DJ. Drucker DJ. Mol Endocrinol. 2003 Feb;17(2):161-71. doi: 10.1210/me.2002-0306. Mol Endocrinol. 2003. PMID: 12554744 Review.
The role of GLP-1 in the life and death of pancreatic beta cells.
Perfetti R, Hui H. Perfetti R, et al. Horm Metab Res. 2004 Nov-Dec;36(11-12):804-10. doi: 10.1055/s-2004-826167. Horm Metab Res. 2004. PMID: 15655712 Review.
[Miniglucagon: is the precursor a traitor to its family or a genius? ].
Bataille D, Fontés G, Costes S, Longuet C, Dalle S. Bataille D, et al. Journ Annu Diabetol Hotel Dieu. 2004:139-49. Journ Annu Diabetol Hotel Dieu. 2004. PMID: 15259312 Review. French. No abstract available.
Glucagon-like peptide 1 agonists and the development and growth of pancreatic beta-cells.
List JF, Habener JF. List JF, et al. Am J Physiol Endocrinol Metab. 2004 Jun;286(6):E875-81. doi: 10.1152/ajpendo.00007.2004. Am J Physiol Endocrinol Metab. 2004. PMID: 15140754 Review.
Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide.
Fehmann HC, Göke R, Göke B. Fehmann HC, et al. Endocr Rev. 1995 Jun;16(3):390-410. doi: 10.1210/edrv-16-3-390. Endocr Rev. 1995. PMID: 7671853 Review. No abstract available.

See all similar articles

Cited by

Exendin-4 promotes liver cell proliferation and enhances the PDX-1-induced liver to pancreas transdifferentiation process.
Aviv V, Meivar-Levy I, Rachmut IH, Rubinek T, Mor E, Ferber S. Aviv V, et al. J Biol Chem. 2009 Nov 27;284(48):33509-20. doi: 10.1074/jbc.M109.017608. Epub 2009 Sep 15. J Biol Chem. 2009. PMID: 19755420 Free PMC article.
A physiologic and pharmacological basis for implementation of incretin hormones in the treatment of type 2 diabetes mellitus.
Freeman JS. Freeman JS. Mayo Clin Proc. 2010 Dec;85(12 Suppl):S5-S14. doi: 10.4065/mcp.2010.0467. Epub 2010 Nov 24. Mayo Clin Proc. 2010. PMID: 21106868 Free PMC article. Review.
Excessive islet NO generation in type 2 diabetic GK rats coincides with abnormal hormone secretion and is counteracted by GLP-1.
Salehi A, Meidute Abaraviciene S, Jimenez-Feltstrom J, Ostenson CG, Efendic S, Lundquist I. Salehi A, et al. PLoS One. 2008 May 14;3(5):e2165. doi: 10.1371/journal.pone.0002165. PLoS One. 2008. PMID: 18478125 Free PMC article.
Incretin effects on β-cell function, replication, and mass: the human perspective.
Garber AJ. Garber AJ. Diabetes Care. 2011 May;34 Suppl 2(Suppl 2):S258-63. doi: 10.2337/dc11-s230. Diabetes Care. 2011. PMID: 21525465 Free PMC article. No abstract available.
The use of exenatide in islet transplant recipients with chronic allograft dysfunction: safety, efficacy, and metabolic effects.
Froud T, Faradji RN, Pileggi A, Messinger S, Baidal DA, Ponte GM, Cure PE, Monroy K, Mendez A, Selvaggi G, Ricordi C, Alejandro R. Froud T, et al. Transplantation. 2008 Jul 15;86(1):36-45. doi: 10.1097/TP.0b013e31817c4ab3. Transplantation. 2008. PMID: 18622276 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- ClinicalTrials.gov